Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSilver Bullet Regulatory News (SBDS)

Share Price Information for Silver Bullet (SBDS)

Share Price is delayed by 15 minutes
Get Live Data
26.00    3.00 (13.04%)
Bid:
25.00
Ask:
27.00
Spread: 2.00 (8.00%)
Market Cap: £4.97m
SBDS Live PriceLast checked at - London Stock Exchange

Intraday Silver Bullet Share Chart

Issue of Equity

18 Jul 2025 07:00

RNS Number : 5320R
Silver Bullet Data Services Grp PLC
18 July 2025
 

18 July 2025

 

Silver Bullet Data Services Group Plc

("Silverbullet" or the "Company")

 

Issue of Equity

 

Silverbullet, a provider of AI driven digital transformation services and products, announces that it has agreed to issue 156,116 new Ordinary Shares at the Issue Price of 30 pence per share to an adviser of the Company in lieu of fees in respect of the Fundraise.

 

Admission and Total Voting Rights

Application has been made to the London Stock Exchange for the 156,116 Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective on or around 23 July 2025.

 

Upon Admission, the Company's issued ordinary share capital will consist of 19,127,114 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, from Admission the total number of Ordinary Shares and voting rights in the Company will be 19,127,114. With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The new Ordinary Shares will, on Admission, rank pari passu in all respects with the Company's existing Ordinary Shares.

 

Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 7.00 a.m. on 24 June 2025.

 

 

For further information please contact:

Silverbullet Ian James (CEO) / Chris Ellis (CFO)

via IFC

 Strand Hanson Limited - Financial and Nominated Adviser James Spinney / James Bellman / Robert Collins

0207 409 3494

Oberon Capital - Joint Broker

Mike Seabrook / Jessica Cave

020 3179 5300

Zeus Capital Limited - Joint Broker Simon Johnson / Jake Walker

0203 829 5000

IFC Advisory Graham Herring / Tim Metcalfe / Florence Staton

020 3934 663007793 839 024

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESFWFEWEISEEW
12
Date   Source Headline
15th Apr 20267:00 amRNSQ1 Trading Update
31st Mar 20266:16 pmRNSHolding(s) in Company
31st Mar 202611:40 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading Update
22nd Oct 20255:25 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSInterim Results
16th Sep 20257:00 amRNSBoard Changes
12th Aug 20254:27 pmRNSResult of AGM
18th Jul 20257:00 amRNSNotice of AGM
18th Jul 20257:00 amRNSIssue of Equity
9th Jul 202511:22 amRNSChange of Registered Address
4th Jul 202512:01 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSHolding(s) in Company
30th Jun 20255:13 pmRNSFinal Results for the year ended 31 December 2024
27th Jun 20251:12 pmRNSHolding(s) in Company
25th Jun 20253:06 pmRNSResult of WRAP Retail Offer
24th Jun 20257:01 amRNSWRAP Retail Offer for up to £60,000
24th Jun 20257:00 amRNSFundraise, CLN Restructure & Broker Appointment
9th May 202510:18 amRNSConvertible Loan Note Fundraise of £200,000
8th May 20257:00 amRNSQ1 2025 Update & New Business Wins
3rd Apr 20257:00 amRNSHolding(s) in Company
26th Feb 20257:00 amRNSTrading Update
8th Jan 20257:00 amRNS4D AI Integration with Global Demand-Side Platform
20th Nov 20247:00 amRNSNew contract wins and positive trading EBITDA
11th Nov 20247:00 amRNSAcquisition
24th Oct 20247:00 amRNSTrading Update and Working Capital Facility
18th Oct 20241:34 pmRNSHolding(s) in Company
10th Oct 20244:15 pmRNSHolding(s) in Company
20th Sep 202412:26 pmRNSHolding(s) in Company
13th Sep 20242:59 pmRNSHolding(s) in Company
11th Sep 20247:00 amRNSInterim Results
14th Aug 202411:13 amRNSResult of AGM
14th Aug 20247:00 amRNS4D AI Contracts and Appointment of Joint Broker
23rd Jul 20247:00 amRNSNotice of AGM
15th Jul 20247:00 amRNSContract Wins and Working Capital Facility
29th May 20247:00 amRNSFinal Results for the year ended 31 December 2023
9th Apr 20247:00 amRNSBoard Changes
21st Mar 20247:00 amRNSContract Wins and Renewals
20th Mar 20243:48 pmRNSExercise of Options
29th Feb 20247:00 amRNSTrading Update
27th Feb 20247:00 amRNSUS$2.3m Contract Win with Mars
7th Feb 20242:49 pmRNSExercise of Options
5th Dec 20233:46 pmRNSHolding(s) in Company
5th Dec 202310:56 amRNSHolding(s) in Company
29th Nov 20237:00 amRNSPlacing to raise £1 million
15th Nov 20237:00 amRNSLaunch of AI Powered Insights Platform
10th Nov 20232:16 pmRNSDirector Dealing
13th Oct 20233:58 pmRNSExercise of Options
28th Sep 20237:00 amRNSInterim Results
19th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.